Chembio Diagnostics, Inc. (CEMI.OB) Experiences Record Revenues for Second Quarter
Chembio Diagnostics develops, manufactures, and markets proprietary diagnostic tests for the healthcare industry. The company's rapid HIV testing product is known as the HIV STAT-PAK®, and is patented and fully approved by the FDA. The company recently reported record-breaking total revenues for the quarter ended June 30th, 2008. This year's second quarter led to the lowest losses for the company since 2004, as well as astonishingly high total revenue. In total, revenues for the quarter reached $2.72 million, increasing more than eight percent over the $2.5 million recorded in the first three months of 2008. Of the $2.72 million, $2.21…